Rifaximin Does Not Increase the Rate of 30-Day Mortality in Patients With Cirrhosis and Daptomycin in Two National US-Based Cohorts

Affiliations

• ¹ Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia.
• ² Department of Medicine, Virginia Commonwealth University, Richmond, Virginia.
• ³ Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
• ⁴ Department of Medicine, Virginia Commonwealth University, Richmond, Virginia. Electronic address: jasmohan.bajaj@vcuhealth.org.